Solitary Fibrous Tumors and So-Called Hemangiopericytoma

Sarcoma · 2012 · Classic · cited 97 times

Nicolas Penel, Éric Amela, Gauthier Decanter, Y Robin, Perrine Marec‐Bérard

General Oncology Department, Centre Oscar Lambret, 3 Rue F Combemale, France

Orthopaedic Oncology

SUMMARY — THE REDUCTIONSolitary fibrous tumor and hemangiopericytoma have overlapping features; understanding malignancy criteria and systemic treatment options guides management strategy.
Abstract, as published

We have reviewed the literature data regarding the spectrum of tumors including solitary fibrous tumor and hemangiopericytoma with special focus on definition of the disease, discussion of the criteria for malignancy, and the key elements of standard treatment of localized disease. We have discussed the emerging concepts on the tumor biology and the different systemic treatments (chemotherapy and molecular-targeted therapies).

Featured in the 2026-07-16 issue.

← A System for the Functional Evaluation of Reconstructive Proc…Enhancing Osteosarcoma Survival Predictions: A Comparative St… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.